GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » Additional Paid-In Capital

Surmodics (STU:SU6) Additional Paid-In Capital : €39.4 Mil(As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Surmodics Additional Paid-In Capital?


Surmodics's quarterly additional paid-in capital increased from Dec. 2023 (€34.5 Mil) to Mar. 2024 (€37.0 Mil) and increased from Mar. 2024 (€37.0 Mil) to Jun. 2024 (€39.4 Mil).

Surmodics's annual additional paid-in capital increased from Sep. 2021 (€18.4 Mil) to Sep. 2022 (€29.1 Mil) and increased from Sep. 2022 (€29.1 Mil) to Sep. 2023 (€34.4 Mil).


Surmodics Additional Paid-In Capital Historical Data

The historical data trend for Surmodics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Additional Paid-In Capital Chart

Surmodics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.75 13.05 18.36 29.06 34.39

Surmodics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.70 34.39 34.50 37.05 39.37

Surmodics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Surmodics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Surmodics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics Headlines

No Headlines